Bioscience Animal Health Stock Short Ratio
| BIS Stock | 3.40 0.06 1.73% |
Bioscience Animal Health fundamentals help investors to digest information that contributes to Bioscience Animal's financial success or failures. It also enables traders to predict the movement of Bioscience Stock. The fundamental analysis module provides a way to measure Bioscience Animal's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioscience Animal stock.
Bioscience |
Bioscience Animal Health Company Short Ratio Analysis
Bioscience Animal's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Bioscience Animal Health has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Consumer Defensive sector and 100.0% lower than that of the Packaged Foods industry. The short ratio for all Thailand stocks is 100.0% higher than that of the company.
Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Bioscience Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0444 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 2.37 B | |||
| Shares Outstanding | 314 M | |||
| Shares Owned By Insiders | 84.04 % | |||
| Price To Book | 3.40 X | |||
| Price To Sales | 1.13 X | |||
| Revenue | 2.2 B | |||
| Gross Profit | 357.86 M | |||
| EBITDA | 80.95 M | |||
| Book Value Per Share | 2.38 X | |||
| Earnings Per Share | 0.20 X | |||
| Market Capitalization | 2.75 B | |||
| Annual Yield | 0.01 % | |||
| Last Dividend Paid | 0.47 |
About Bioscience Animal Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioscience Animal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioscience Animal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioscience Animal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Bioscience Stock
Bioscience Animal financial ratios help investors to determine whether Bioscience Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioscience with respect to the benefits of owning Bioscience Animal security.